# Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

> **NCT02755428** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chinese Academy of Sciences** · enrollment: 10 (estimated)

## Conditions studied

- Dry Age-related Macular Degeneration

## Interventions

- **BIOLOGICAL:** retinal pigment epithelium transplantation

## Key facts

- **NCT ID:** NCT02755428
- **Lead sponsor:** Chinese Academy of Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01
- **Primary completion:** 2019-01
- **Final completion:** 2020-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02755428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02755428, "Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02755428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*